Scholars@Duke publication: Efficacy of Genome Editing in Infant Mice with Glycogen Storage Disease Type Ia

Efficacy of Genome Editing in Infant Mice with Glycogen Storage Disease Type Ia

Publication , Conference

Arnson, B; Li, S; Gheorgiu, D; Brooks, E; Han, S-O; Ilich, E; Cullen, BR; Koeberl, DD

Published in: MOLECULAR THERAPY

2022

MOLECULAR THERAPY

1525-0024

1525-0016

2022

115 / 116

APA

Chicago

ICMJE

MLA

NLM

Arnson, B., Li, S., Gheorgiu, D., Brooks, E., Han, S.-O., Ilich, E., … Koeberl, D. D. (2022). Efficacy of Genome Editing in Infant Mice with Glycogen Storage Disease Type Ia. In MOLECULAR THERAPY (Vol. 30, pp. 115–116).

Arnson, Benjamin, Songtao Li, Dorothy Gheorgiu, Elizabeth Brooks, Sang-Oh Han, Ekaterina Ilich, Bryan R. Cullen, and Dwight D. Koeberl. “Efficacy of Genome Editing in Infant Mice with Glycogen Storage Disease Type Ia.” In MOLECULAR THERAPY, 30:115–16, 2022.

Arnson B, Li S, Gheorgiu D, Brooks E, Han S-O, Ilich E, et al. Efficacy of Genome Editing in Infant Mice with Glycogen Storage Disease Type Ia. In: MOLECULAR THERAPY. 2022. p. 115–6.

Arnson, Benjamin, et al. “Efficacy of Genome Editing in Infant Mice with Glycogen Storage Disease Type Ia.” MOLECULAR THERAPY, vol. 30, no. 4, 2022, pp. 115–16.

Arnson B, Li S, Gheorgiu D, Brooks E, Han S-O, Ilich E, Cullen BR, Koeberl DD. Efficacy of Genome Editing in Infant Mice with Glycogen Storage Disease Type Ia. MOLECULAR THERAPY. 2022. p. 115–116.

MOLECULAR THERAPY

1525-0024

1525-0016

2022

115 / 116